Skip to main content

Jose Maria Zuazo Morquecho

Institutions of which they are part

Liver Diseases
Vall Hebron Institut de Recerca

Jose Maria Zuazo Morquecho

Institutions of which they are part

Liver Diseases
Vall Hebron Institut de Recerca

Related news

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

The research team used nanotechnology to deliver the drug directly to liver cells, which eliminated side effects without reducing effectiveness.

Related professionals

Santiago Aguade Bruix

Santiago Aguade Bruix

Main researcher
Molecular Medical Imaging
Read more
Gloria Fatou Royo Gomes

Gloria Fatou Royo Gomes

Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more
Mª Engracia Perez Mezquina

Mª Engracia Perez Mezquina

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more
Josep Massons Albareda

Josep Massons Albareda

Postdoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.